Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
cell division cycle 37 pseudogene 1 (CDC37P1) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but generally non-functional—having lost its protein-coding potential or not being transcribed or translated into a functional protein. CDC37P1 shares sequence similarity with the functional CDC37 gene, which encodes a molecular chaperone involved in cell cycle regulation and signal transduction. However, CDC37P1 itself is not known to produce a functional protein or participate in any known biological pathways, disease processes, or drug interactions. It is not considered a therapeutic target, and its nomenclature should not be confused with the functional CDC37 gene[1]. CDC37P1 is a pseudogene, not a biologically active protein-coding gene, and is distinct from the clinically relevant molecular chaperone CDC37 (involved in protein kinase chaperoning and oncogenesis)[1]. No evidence supports its involvement as a therapeutic or diagnostic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cell division cycle 37 pseudogene 1 (CDC37P1).